Related Experiment Video

Updated: May 8, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

Role of toll-like receptors in systemic sclerosis

Marzena Ciechomska1, Rachel Cant, James Finnigan

  • 1Musculoskeletal Research Group, Institute of Cellular Medicine, 4th Floor Cookson Building, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK.

Expert Reviews in Molecular Medicine
|August 30, 2013
PubMed

Insights

Toll-like receptors (TLRs) recognize microbial and endogenous molecules, playing a key role in autoimmune diseases like systemic sclerosis (SSc). Targeting TLRs may offer new therapies for SSc and other autoimmune conditions.

Area of Science:

  • Immunology
  • Autoimmune Diseases
  • Molecular Biology

Background:

  • Toll-like receptors (TLRs) are crucial for identifying microbial/viral compounds and endogenous molecules released during cell damage.
  • Systemic sclerosis (SSc) involves vascular injury, Raynaud's phenomenon, and skin ischemia, leading to endogenous TLR ligand release.
  • These ligands, potentially complexed with autoantibodies, activate intracellular pathways, driving autoimmunity and fibrosis in SSc.

Purpose of the Study:

  • To review the current understanding of TLR function in autoimmune disorders, focusing on SSc.
  • To explore the role of TLRs in the pathogenesis of SSc, linking immune activation and fibrosis.
  • To propose the TLR system as a novel therapeutic target for SSc and other multi-systemic autoimmune diseases.

Main Methods:

  • Literature review integrating current knowledge on TLRs in autoimmunity.
  • Analysis of TLR-mediated signaling pathways in the context of SSc pathogenesis.
  • Examination of interferon (IFN) gene signatures in SSc and their relation to TLR activation.

Main Results:

  • TLRs recognize both external microbial/viral compounds and internal danger signals.
  • Endogenous TLR ligands released during SSc-related tissue damage may initiate and perpetuate autoimmune responses.
  • An interferon (IFN) gene signature is observed in SSc peripheral blood, suggesting a link to TLR activation.

Conclusions:

  • TLRs are implicated in the pathogenesis of SSc by linking immune activation to tissue fibrosis.
  • Understanding TLR-mediated mechanisms is essential for developing targeted therapies.
  • The TLR system represents a promising new therapeutic target for systemic sclerosis and other autoimmune diseases.

More Related Videos

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...